Sable Bio
Last verified 2026-06-16. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.4Mattributed |
|---|---|
| Latest round | strategic, $3.4M, 2026-02-01attributed |
| Founded | 2023 |
| Headquarters | London, UK |
| Industry | bio |
| Stage | seed |
| Website | sablebio.com |
AI drug safety
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-02-01 | strategic | $3.4M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Strategic, $3.4M | attributed | eu-startups named as publisher. No document URL on file. |
| Total raised $3.4M | attributed | eu-startups named as publisher. No document URL on file. |
| Company existence | self-reported | sablebio.com, read 2026-06-16 |
| Description | self-reported | sablebio.com, read 2026-06-16 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.